Refine
Has Fulltext
- yes (2)
Is part of the Bibliography
- yes (2)
Document Type
- Journal article (1)
- Doctoral Thesis (1)
Keywords
- CXCR4 (1)
- CXCR4/SDF-1 (1)
- FDG PET/CT (1)
- Thymuskarzinome (1)
- autologous transplantation (1)
- bone disease (1)
- c-kit (1)
- cancer (1)
- cells (1)
- chemokine receptor (1)
Untersuchungen zur Expression der Rezeptortyrosinkinase c-kit in Thymuskarzinomen und Thymomen
(2005)
Thymome und Thymuskarzinome sind seltene mediastinale Neoplasien. In der vorliegenden Arbeit wurde die Expression und der Aktivierungsstatus der Rezeptortyrosinkinase c-kit in Thymustumoren untersucht und deren diagnostische und klinische Relevanz aufgezeigt. Das c-kit-Gen wurde auf Mutationen untersucht sowie der Aktivierungsstatus im c-kit-Transduktionspfad nachgeschalteter Proteine festgestellt.
CXCR4 is a G-protein-coupled receptor that mediates recruitment of blood cells toward its ligand SDF-1. In cancer, high CXCR4 expression is frequently associated with tumor dissemination andpoor prognosis. We evaluated the novel CXCR4 probe [\(^{68}\)Ga]Pentixafor for invivo mapping of CXCR4 expression density in mice xenografted with human CXCR4-positive MM cell lines and patients with advanced MM by means of positron emission tomography (PET). [\(^{68}\)Ga]Pentixafor PET provided images with excellent specificity and contrast. In 10 of 14 patients with advanced MM [\(^{68}\)Ga]Pentixafor PET/CT scans revealed MM manifestations, whereas only nine of 14 standard [\(^{18}\)F]fluorodeoxyglucose PET/CT scans were rated visually positive. Assessment of blood counts and standard CD34\(^{+}\) flow cytometry did not reveal significant blood count changes associated with tracer application. Based on these highly encouraging data on clinical PET imaging of CXCR4 expression in a cohort of MM patients, we conclude that [\(^{68}\)Ga]Pentixafor PET opens a broad field for clinical investigations on CXCR4 expression and for CXCR4-directed therapeutic approaches in MM and other diseases.